-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Many European countries have suspended vaccination of AstraZeneca's new crown vaccine.
Overseas Network, March 20, US media reported that scientists from Europe believe that thrombosis and thromboembolism are related to the vaccination of AstraZeneca's new crown vaccine.
According to the "Wall Street Journal" on the 19th, scientists in Germany and Norway said that they have determined the potential link between the AstraZeneca vaccine and thrombosis reports.
Pål André Holme, Professor of Hematology and Chief Physician at Oslo University Hospital in Norway, said, “These people will have such an immune response only because of the vaccine.
According to a CNN report on the 19th, in the European Union and the United Kingdom, about 17 million people have been vaccinated with AstraZeneca.